Triethylamine → (S)-4-[4-(4-Cyclopropylcarbamoyl-phenyl)-thiazol-2-ylcarbamoyl]-oxazolidine-3-carboxylic acid benzyl ester

HRID 737172Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 737172
[CH2:1]([O:8][C:9]([N:11]1[C@H:15]([C:16]([OH:18])=O)[CH2:14][O:13][CH2:12]1)=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C(N(CC)CC)C.FC(F)(F)C(OC1C(F)=C(F)C(F)=C(F)C=1F)=O.FC(F)(F)C(O)=O.[NH2:51][C:52]1[S:53][CH:54]=[C:55]([C:57]2[CH:68]=[CH:67][C:60]([C:61]([NH:63][CH:64]3[CH2:66][CH2:65]3)=[O:62])=[CH:59][CH:58]=2)[N:56]=1>CN(C=O)C>[CH2:1]([O:8][C:9]([N:11]1[C@H:15]([C:16](=[O:18])[NH:51][C:52]2[S:53][CH:54]=[C:55]([C:57]3[CH:58]=[CH:59][C:60]([C:61](=[O:62])[NH:63][CH:64]4[CH2:66][CH2:65]4)=[CH:67][CH:68]=3)[N:56]=2)[CH2:14][O:13][CH2:12]1)=[O:10])[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1

Komponenten

6

Versuchsvorschrift

(S)-Oxazolidine-3,4-dicarboxylic acid 3-benzyl ester (51.3 mg, 0.20 mmol) was dissolved in DMF (1.5 mL). Triethylamine (56 μL, 0.40 mmol) and pentafluorophenyl trifluoroacetate (35 μL, 0.20 mmol) were added, and the reaction was allowed to stir at ambient temperature for 25 minutes. Then 4-(2-Amino-thiazol-4-yl)-N-cyclopropyl-benzamide trifluoroacetic acid salt (148.8 mg, 0.40 mmol) was added, and the reaction was stirred at ambient temperature overnight. The reaction was filtered and purified by reverse phase HPLC to give the desired product. Yield 10.2 mg. MS: 493.1 (M+H+); H1 NMR (DMSO-d6): δ(ppm) 0.52-0.74 (m, 4H), 4.05-4.37 (m, 2H), 4.58-4.69 (m, 1H), 4.90-5.17 (m, 4H), 7.00-7.45 (m, 4H), 7.72-7.98 (m, 5H), 8.37-8.48 (m, 1H), 12.48-12.51 (s, 1H).

Aufarbeitung

  1. stirringthe reaction was stirred at ambient temperature overnight
  2. filtrationThe reaction was filtered
  3. custompurified by reverse phase HPLC

Quellen und Nachweise

ORD-Eintrag
ord-0f5490f86f6a4bfca8a7be48ded3d6ce
Quelldatensatz
uspto-grants-2009_09
Patentnummer
US07595398B2

Notizen zur Reaktion

Wird geladen…